Trident Texofab Ltd

BSE: 540726

89

total announcements

540726.BO · 15 min delayed

BSEInsider Trading / SASTPledge26 Aug 2026

Trident Texofab Ltd

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust

Hardik Desai Family Trust has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, acquiring 10,33,691 shares of Trident Texofab Ltd, representing 6.89% of the company's total share capital.

Read more →📎 1 attachment
BSEInsider Trading / SASTPromoter Reclassif.20 Aug 2026

Trident Texofab Ltd

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust

Hardik Desai Family Trust has made a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a change in the promoter group's shareholding in Trident Texofab Ltd. The trust acquired 39,425 shares carrying voting rights, increasing its holding to 6.79% of the total voting capital.

Read more →📎 1 attachment
BSECompany UpdateAuditor Change10 Aug 2026

Trident Texofab Ltd

The Board took on record Resignation of M/s. Shah Kailash and Associates LLP, Chartered Accountant, FRN: 109647W as Statutory Auditor of the Company with effect from 10th August, 2026

Trident Texofab Ltd has announced the resignation of its statutory auditor, M/s. Shah Kailash and Associates LLP, effective August 10, 2026. The company has also announced the appointment of M/s. Priti Agrawal & Co. as its internal auditor for the financial year 2026-27. Additionally, the company has released unaudited financial results for the quarter ended June 30, 2026.

Read more →📎 1 attachment
BSECompany UpdateResults10 Aug 2026

Trident Texofab Ltd

The Board of Directors inter-alia has approved the Appointment of M/s. Prit Agrawal & CO., Chartered Accountant having FRN No. 152249W as an Internal Auditor for the financial year 2026-27.

Trident Texofab Ltd has announced the appointment of M/s. Prit Agrawal & Co. as an internal auditor for the financial year 2026-27. The company has also disclosed unaudited financial results for the quarter ended June 30, 2026, along with a limited review report by the statutory auditor. The results show a profit of Rs. 52.18 crore for the quarter, with a net profit of Rs. 70.16 crore for the period.

Read more →📎 1 attachment
BSEResult▼ NegativeResults10 Aug 2026

Trident Texofab Ltd

Un-Audited Financial Results for the quarter ended on June 30, 2026 along with Limited Review Report on said results by the Statutory Auditor of the Company

Trident Texofab Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2,614.26 crore, a decline of 22.3% from ₹3,357.02 crore in the same quarter last year. The company has also reported a net loss of ₹200.94 crore for the quarter, compared to a net profit of ₹101.59 crore in the same quarter last year.

Read more →📎 1 attachment
BSEBoard Meeting▼ NegativeResults10 Aug 2026

Trident Texofab Ltd

Outcome of Board Meeting held on 10.08.2026

Trident Texofab Ltd announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2,614.26 crore, a decrease of 21.5% from ₹3,357.02 crore in the same quarter last year. The company reported a net loss of ₹200.94 crore, compared to a net profit of ₹101.59 crore in the same quarter last year. The board of directors approved the appointment of M/s. Priti Agrawal & Co. as the internal auditor for the financial year 2026-27.

Read more →📎 1 attachment
← PreviousPage 5 of 5